Breaking News Instant updates and real-time market news.

BA

Boeing

$350.57

-1.93 (-0.55%)

08:04
05/24/19
05/24
08:04
05/24/19
08:04

Morgan Stanley keeps Overweight rating on Boeing after 'good enough' FAA meeting

Morgan Stanley analyst Rajeev Lalwani said he views the FAA meeting on May 23 with global regulators on the status of the 737 MAX as supportive of Boeing and "good enough" given that there were no major setbacks in progressing on the return to service of the MAX, there appeared to be a collaborative approach among aviation authorities and a 1-2 month timeline was not ruled out. Lalwani, who thinks the dialogue is shifting more towards when the aircraft can get back into service as opposed to if, said he remains comfortable with his Overweight rating and $500 price target on Boeing shares, especially with the shares down about 20% from their recent highs.

  • 29

    May

  • 05

    Jun

BA Boeing
$350.57

-1.93 (-0.55%)

05/24/19
RHCO
05/24/19
NO CHANGE
Target $137
RHCO
RBC Bearings price target raised to $137 from $125 at SunTrust
SunTrust analyst Michael Ciarmoli raised his price target on RBC Bearings (ROLL) to $137 after its Q4 earnings beat and above-consensus outlook for Q1, saying the declines in its organic industrial revenue growth were offset by strength in the aerospace segment along with backlog growth and record margins. The analyst believes the company can sustain continued growth acceleration this year given the "manageable" risks related to Boeing's (BA) 737 MAX grounding, forecasting up to 100bps in margin expansion during FY20. Ciarmoli also keeps his Hold rating on the shares based on RBC Bearings' "full valuation."
05/17/19
BARD
05/17/19
NO CHANGE
Target $470
BARD
Outperform
Boeing designated as bullish Fresh Pick at Baird
Baird analyst Peter Arment designated Boeing as a bullish Fresh Pick, saying he expects the path for the 737 MAX un-grounding to become more clear after the upcoming meeting on May 23 with the FAA and global regulators. The software fix is tracking to be certified within days with FAA regulatory approval taking the lead and other major global regulators set to approve shortly thereafter, Arment tells investors in a research note, adding that this sets up 737 deliveries to re-commence in the third quarter. Arment, who maintains an Outperform rating and $470 price target, says he remains comfortable buying Boeing at current levels for both short and long term investors.
05/07/19
05/07/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fluor (FLR) downgraded to Neutral from Buy at Goldman Sachs with analyst Jerry Revich seeing an unclear medium-term margin outlook amid the company's CEO transition and further project writedowns in Q1. 2. Gardner Denver (GDI) downgraded to Neutral from Buy at UBS with analyst Damian Karas downgraded saying the shares are due for a "breather" following the recent run. 3. Boeing (BA) downgraded to Equal Weight from Overweight at Barclays with analyst David Strauss expecting the recovery of 737 Max production to take longer than expected. 4. Discover (DFS) downgraded to Perform from Outperform at Oppenheimer with analyst Dominick Gabriele seeing limited upside in the shares following the rally year-to-date now that his estimates are in-line with the consensus. 5. Cambrex (CBM) downgraded to Outperform from Strong Buy at First Analysis with analyst Steven Schwartz saying the company's valuation multiple is now in-line with peers following the recent share price appreciation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/07/19
RHCO
05/07/19
NO CHANGE
Target $54
RHCO
Buy
Ducommun price target raised to $54 from $48 at SunTrust
SunTrust analyst Michael Ciarmoli raised his price target on Ducommun (DCO) to $54 and kept his Buy rating after its Q1 earnings beat and record margins. The analyst notes that the sales mix and rate increases generated additional tailwinds for the company in the quarter, but he also expects these trends to be sustainable. Ciarmoli adds that the risks related to the Boeing (BA) 737 Max grounding "appear to be manageable."

TODAY'S FREE FLY STORIES

EIDX

Eidos Therapeutics

$34.87

-1.4 (-3.86%)

07:37
07/22/19
07/22
07:37
07/22/19
07:37
Recommendations
Eidos Therapeutics analyst commentary  »

Eidos Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SALT

Scorpio Bulkers

$6.25

0.165 (2.71%)

07:37
07/22/19
07/22
07:37
07/22/19
07:37
Earnings
Scorpio Bulkers reports Q2 adjusted EPS 58c, consensus (21c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

OFG

OFG Bancorp

$23.30

-0.02 (-0.09%)

07:36
07/22/19
07/22
07:36
07/22/19
07:36
Earnings
OFG Bancorp reports Q2 EPS 43c, consensus 43c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

ZVO

Zovio

$4.02

0.02 (0.50%)

, DAL

Delta Air Lines

$60.91

-1.75 (-2.79%)

07:35
07/22/19
07/22
07:35
07/22/19
07:35
Hot Stocks
Zovio teams up with Delta Air Lines for tuition assistance program »

Zovio has teamed up with…

ZVO

Zovio

$4.02

0.02 (0.50%)

DAL

Delta Air Lines

$60.91

-1.75 (-2.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$279.06

-4.87 (-1.72%)

07:35
07/22/19
07/22
07:35
07/22/19
07:35
Hot Stocks
Lennox cuts FY19 free cash flow view to approximately $390M from $420M »

Reiterating guidance for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

CHCO

City Holding

$73.71

-0.21 (-0.28%)

07:35
07/22/19
07/22
07:35
07/22/19
07:35
Earnings
City Holding reports Q2 EPS $1.38, consensus $1.30 »

Reports Q2 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAC

Bank of America

$29.41

-0.07 (-0.24%)

, MU

Micron

$45.51

0.85 (1.90%)

07:35
07/22/19
07/22
07:35
07/22/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BAC

Bank of America

$29.41

-0.07 (-0.24%)

MU

Micron

$45.51

0.85 (1.90%)

ITCI

Intra-Cellular

$11.84

0.06 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 06

    Aug

  • 06

    Sep

  • 27

    Sep

  • 16

    Oct

07:35
07/22/19
07/22
07:35
07/22/19
07:35
General news
Treasury Market Outlook: Treasury yields are lower »

Treasury Market Outlook:…

UNCFF

UniCredit

$0.00

(0.00%)

07:34
07/22/19
07/22
07:34
07/22/19
07:34
Periodicals
UniCredit may cut up to 10,000 jobs in effort to reduce costs, Bloomberg reports »

UniCredit is considering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VYST

Vystar Corp

$0.00

(0.00%)

07:34
07/22/19
07/22
07:34
07/22/19
07:34
Hot Stocks
Vystar Corp acquires controlling interest in Rotmans Furniture for $2.03M »

Vystar announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$258.12

4.3 (1.69%)

07:34
07/22/19
07/22
07:34
07/22/19
07:34
Downgrade
Tesla rating change at Roth Capital »

Tesla downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

LII

Lennox

$279.06

-4.87 (-1.72%)

07:33
07/22/19
07/22
07:33
07/22/19
07:33
Earnings
Lennox cuts FY19 adjusted revenue growth view to 2%-5% from 3%-7% 

FY19 consensus $3.89B.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

07:33
07/22/19
07/22
07:33
07/22/19
07:33
Hot Stocks
Biohaven enrollment for Phase 2/3 trial of troriluzole progresses on timeline »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

AAPL

Apple

$202.62

-3.02 (-1.47%)

07:32
07/22/19
07/22
07:32
07/22/19
07:32
Recommendations
Apple analyst commentary at Morgan Stanley »

Morgan Stanley says Apple…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 03

    Aug

LII

Lennox

$279.06

-4.87 (-1.72%)

07:32
07/22/19
07/22
07:32
07/22/19
07:32
Hot Stocks
Breaking Hot Stocks news story on Lennox »

Lennox backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

AXP

American Express

07:31
07/22/19
07/22
07:31
07/22/19
07:31
Recommendations
American Express analyst commentary  »

American Express price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

AXP

American Express

$124.82

-3.58 (-2.79%)

07:31
07/22/19
07/22
07:31
07/22/19
07:31
Recommendations
American Express analyst commentary  »

American Express price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

LII

Lennox

$279.06

-4.87 (-1.72%)

07:31
07/22/19
07/22
07:31
07/22/19
07:31
Earnings
Lennox cuts FY19 adjusted EPS view to $11.30-$11.90 from $12.00-$12.60 

FY19 consensus $12.29.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

LII

Lennox

$279.06

-4.87 (-1.72%)

07:30
07/22/19
07/22
07:30
07/22/19
07:30
Earnings
Lennox reports Q2 adjusted EPS $3.74, consensus $4.12 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 13

    Nov

SKIS

Peak Resorts

$5.14

0.04 (0.78%)

07:30
07/22/19
07/22
07:30
07/22/19
07:30
Hot Stocks
Breaking Hot Stocks news story on Peak Resorts »

Peak Resorts trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$2.99

-0.38 (-11.28%)

07:30
07/22/19
07/22
07:30
07/22/19
07:30
Hot Stocks
Breaking Hot Stocks news story on Intec Pharma »

Intec Pharma trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMBM

Cambium Networks

$10.35

0.42 (4.23%)

07:27
07/22/19
07/22
07:27
07/22/19
07:27
Initiation
Cambium Networks initiated at Oppenheimer »

Cambium Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OLED

Universal Display

$205.90

-0.74 (-0.36%)

07:27
07/22/19
07/22
07:27
07/22/19
07:27
Downgrade
Universal Display rating change at Roth Capital »

Universal Display…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

NOW

ServiceNow

$289.82

-4.73 (-1.61%)

07:26
07/22/19
07/22
07:26
07/22/19
07:26
Recommendations
ServiceNow analyst commentary at RBC Capital »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BHVN

Biohaven Pharmaceutical

$44.16

-0.61 (-1.36%)

07:25
07/22/19
07/22
07:25
07/22/19
07:25
Recommendations
Biohaven Pharmaceutical analyst commentary at Canaccord »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.